Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Elı́as Campo, Elaine S. Jaffe, James R. Cook, et al.
Blood (2022) Vol. 140, Iss. 11, pp. 1229-1253
Open Access | Times Cited: 921

Showing 26-50 of 921 citing articles:

Chronic lymphocytic leukaemia
Nitin Jain, William G. Wierda, Susan O’Brien
The Lancet (2024) Vol. 404, Iss. 10453, pp. 694-706
Closed Access | Times Cited: 13
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial
Vincent Camus, Catherine Thiéblemont, Philippe Gaulard, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 14, pp. 1612-1618
Closed Access | Times Cited: 12
Classifications of cutaneous lymphomas and lymphoproliferative disorders: An update from the EORTC cutaneous lymphoma histopathology group
Werner Kempf, Christina Mitteldorf, Lorenzo Cerroni, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 8, pp. 1491-1503
Closed Access | Times Cited: 12
CAR T‐cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real‐life results of the LOC network
Sylvain Choquet, Carole Soussain, Nabih Azar, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 7, pp. 1240-1249
Open Access | Times Cited: 11
Motive and Opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements-an LLMPP study
Laura K. Hilton, Brett Collinge, Susana Ben‐Neriah, et al.
Blood (2024) Vol. 144, Iss. 5, pp. 525-540
Closed Access | Times Cited: 11
Monoclonal Gammopathies
Rafael Ríos Tamayo
Elsevier eBooks (2024), pp. 358-374
Closed Access | Times Cited: 11
The management of newly diagnosed large B‐cell lymphoma: A British Society for Haematology Guideline
Christopher P. Fox, Sridhar Chaganti, Graham McIlroy, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 4, pp. 1178-1192
Open Access | Times Cited: 10
JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature
Seyed Mohammad Vahabi, Saeed Bahramian, Farzad Esmaeili, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 861-861
Open Access | Times Cited: 9
The follicular lymphoma tumor microenvironment at single-cell and spatial resolution
Andrea J. Radtke, Mark Roschewski
Blood (2024) Vol. 143, Iss. 12, pp. 1069-1079
Closed Access | Times Cited: 8
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review
Lakshmi Nayak, Chetan Bettegowda, Florian Scherer, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 6, pp. 993-1011
Open Access | Times Cited: 8
Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma
Matías Mendeville, Jurriaan Janssen, G. Tjitske Los-de Vries, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Risk analysis of cardiovascular toxicity in patients with lymphoma treated with CD19 CAR T cells
Yang Liu, Xiaoshuang Yuan, Xu Yang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
INDOLENT CLONAL LYMPHOID DISORDERS
Jan Delabie, Ali Sakhdari
Human Pathology (2025), pp. 105715-105715
Closed Access | Times Cited: 1
Diffuse Large B-Cell Lymphoma/High Grade B-Cell Lymphoma with MYC and BCL6 Rearrangements: a study of 60 Cases
Do H. Kim, L. Jeffrey Medeiros, Jie Xu, et al.
Modern Pathology (2025), pp. 100710-100710
Closed Access | Times Cited: 1
Characterization and molecular targeting of CFIm25 (NUDT21/CPSF5) mRNA using miRNAs
Naazneen Khan, Mahesh P. Gupta, Chioniso Patience Masamha
The FASEB Journal (2025) Vol. 39, Iss. 2
Open Access | Times Cited: 1
Risk and prognosis of post-transplant lymphoproliferative disease in Epstein-Barr virus-seronegative kidney transplant recipients - An observational cohort study from Norway and western Denmark
Lene Ugilt Pagter Ludvigsen, Anders Åsberg, Signe Spetalen, et al.
American Journal of Transplantation (2025)
Open Access | Times Cited: 1
Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma
Rebecca L. King, Eric D. Hsi, Wing C. Chan, et al.
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 193-205
Closed Access | Times Cited: 34
Plasma cell neoplasms and related entities—evolution in diagnosis and classification
Falko Fend, Ahmet Doğan, James R. Cook
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 163-177
Open Access | Times Cited: 34
Sutimlimab for Treatment of Cold Agglutinin Disease: Why, How And For Whom?
Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, et al.
Immunotherapy (2022) Vol. 14, Iss. 15, pp. 1191-1204
Open Access | Times Cited: 33
Rosai–Dorfman Disease between Proliferation and Neoplasia
Ismail Elbaz Younes, Lubomir Sokol, Ling Zhang
Cancers (2022) Vol. 14, Iss. 21, pp. 5271-5271
Open Access | Times Cited: 31
Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas
Andrew L. Feldman, Camille Laurent, Marina Narbaitz, et al.
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 265-279
Closed Access | Times Cited: 30
Diffuse Large B-Cell Lymphoma (DLBCL): Early Patient Management and Emerging Treatment Options
Prokop Vodička, Pavel Klener, Marek Trněný
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 1481-1501
Open Access | Times Cited: 30
Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
Irene Dogliotti, Cristina Jiménez, Marzia Varettoni, et al.
Leukemia (2022) Vol. 37, Iss. 2, pp. 388-395
Open Access | Times Cited: 29
Follicular lymphoma and marginal zone lymphoma: how many diseases?
Camille Laurent, James R. Cook, Tadashi Yoshino, et al.
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 149-162
Open Access | Times Cited: 28
Navigating the Evolving Treatment Landscape of Diffuse Large B-Cell Lymphoma
Loretta J. Nastoupil, Nancy L. Bartlett
Journal of Clinical Oncology (2022) Vol. 41, Iss. 4, pp. 903-913
Closed Access | Times Cited: 28

Scroll to top